Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
368
-
Total 13F shares, excl. options
-
89,994,221
-
Shares change
-
+3,031,957
-
Total reported value, excl. options
-
$5,828,633,461
-
Value change
-
+$197,606,819
-
Put/Call ratio
-
1.4%
-
Number of buys
-
169
-
Number of sells
-
-156
-
Price
-
$64.79
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2016
413 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2016.
RESMED INC - Common Stock (RMD) has 368 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89,994,221 shares
of 146,467,184 outstanding shares and own 61.44% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10,686,136 shares), Capital World Investors (8,497,000 shares), BlackRock Fund Advisors (6,135,247 shares), BAILLIE GIFFORD & CO (5,150,770 shares), STATE STREET CORP (4,581,627 shares), BlackRock Institutional Trust Company, N.A. (4,341,613 shares), FMR LLC (4,216,005 shares), Bank of New York Mellon Corp (2,388,501 shares), COMMONWEALTH BANK OF AUSTRALIA (1,987,164 shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1,446,131 shares).
This table shows the top 368 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.